Erik Harris

Erik Harris

Director/Board Member chez DENALI THERAPEUTICS INC.

Fortune : 3 M $ au 31/03/2024

54 ans
Health Technology
Consumer Services
Commercial Services

Profil

Erik C.
Harris
is currently an Independent Director at Denali Therapeutics, Inc. and a Trustee at East Bay Zoological Society.
He previously held positions as the Chief Commercial Officer & Executive VP at Ultragenyx Pharmaceutical, Inc. and as a Senior Director-Marketing & Sales at Elan Corp.
Plc.
He also served as the Manager-Sales & Marketing at Bristol Myers Squibb Co., the Head-Sales & Marketing at Genentech, Inc., the Vice President-Pulmonology Marketing at InterMune, Inc., and the Vice President-Marketing & Sales at Crescendo Bioscience LLC.
Mr. Harris received his undergraduate degree from the United States Naval Academy and his MBA from The Wharton School of the University of Pennsylvania.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
01/03/2024 67 163 ( 0,08% ) 3 M $ 31/03/2024
01/06/2023 11 085 ( 0,01% ) 227 464 $ 31/03/2024

Postes actifs de Erik Harris

SociétésPosteDébut
ULTRAGENYX PHARMACEUTICAL INC. Corporate Officer/Principal 01/01/2017
DENALI THERAPEUTICS INC. Director/Board Member 07/02/2022
Director/Board Member -
Tous les postes actifs de Erik Harris

Anciens postes connus de Erik Harris

SociétésPosteFin
Sales & Marketing 01/06/2017
INTERMUNE INC Sales & Marketing 01/08/2010
Corporate Officer/Principal 01/01/2007
BRISTOL-MYERS SQUIBB COMPANY Sales & Marketing 01/01/2001
Sales & Marketing -
Voir l'expérience en détail de Erik Harris

Formation de Erik Harris

United States Naval Academy Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Erik Harris

Relations

99

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
BRISTOL-MYERS SQUIBB COMPANY

Health Technology

ULTRAGENYX PHARMACEUTICAL INC.

Health Technology

DENALI THERAPEUTICS INC.

Health Technology

Entreprise privées5

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Erik Harris